CCDR: Volume 51-2/3, February/March 2025: Health Economics in Public Health

Table of contents

Health Economics

Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: A multi-model comparison
M Rudd, AE Simmons, GB Gebretekle, AR Tuite

Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: a cost-utility analysis
AE Simmons, GB Gebretekle, R Pless, A Wierzbowski, M Tunis, AR Tuite

Systematic Review

Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults: A systematic review of economic evaluations
AE Simmons, R Ximenes, GB Gebretekle, MI Salvadori, E Wong, AR Tuite

Infographic

Public Health Risks Associated with Dog Importation
Centre for Foodborne, Environmental and Zoonotic Infectious Diseases

Outbreak Report

Summary of the mpox outbreak in Canada, April 28−December 31, 2022
M Bhulabhai, J Venugopal, M Plamondon, G Bergeron, G Cadieux, J Kancir, M Singal, K Twohig, A Zygmunt, E Schillberg, R Ahmad, J Paul

Qualitative Study

Differences in sensationalism in international news media reporting of COVID-19: An exploratory analysis using the Global Public Health Intelligence Network (GPHIN) system
J Przepiorkowski, T Norzin, A Zaghlool, F Tanguay, D Taylor, V Gallant, L Zhao on behalf of the Global Public Health Intelligence Network (GPHIN)

Infographic

Infectious syphilis and congenital syphilis in Canada, 2023
Centre for Communicable Diseases and Infection Control

• Next page